Shamburg News · 8-K filed Nov 4, 2026, 5:22 PM EST
Summit Therapeutics Files Legality Opinion Tied to Shelf Prospectus Supplement
SMMT · Summit Therapeutics Inc.
- Other event
- Financing
- Materiality: low
Summit Therapeutics Inc. filed a prospectus supplement on November 4, 2026 under its automatic shelf registration statement on Form S-3 (Registration No. 333-296642). This 8-K was filed to submit the opinion of Baker & Hostetler LLP on the legality of the common stock issuance, included as Exhibit 5.1, along with the related consent as Exhibit 23.1.
Source: SEC EDGAR, Form 8-K, Items 8.01, 9.01, accession 0001193125-26-447661.
Written from the filing by Shamburg Markets. Figures are as reported by the company.